Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1

Journal of General Virology

Volumn 94, Issue PART3, 2013, Pages 497-506

  Kim, Do Nyun ^a   Seo, Min Koo ^a   Choi, Hoyun ^a   Kim, Su Yeon ^a   Shin, Hee Jong ^a   Yoon, A Ran ^a   Tao, Qian ^b   Rha, Sun Young ^c   Lee, Suk Kyeong ^a  

^a The Catholic University of Korea   (South Korea)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKERATIN; EPSTEIN BARR VIRUS ANTIGEN 1; LATENT MEMBRANE PROTEIN 2A; MICRORNA; PHORBOL DERIVATIVE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH CARCINOMA; VIRUS GENE; WESTERN BLOTTING;

BLOTTING, SOUTHERN; CARCINOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, COMPLEMENT 3D; STOMACH NEOPLASMS; VIRAL PROTEINS;

EID: 84874067404     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.045237-0     Document Type: Article

References (31)

1. Andersson, M. (1975). Amounts of Epstein-Barr virus DNA in somatic cell hybrids between Burkitt lymphoma-derived cell lines. J Virol 16, 1345-1347.
2. Bernasconi, M., Berger, C., Sigrist, J. A., Bonanomi, A., Sobek, J., Niggli, F. K. & Nadal, D. (2006). Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 3, 43.
3. Chesnokova, L. S., Nishimura, S. L. & Hutt-Fletcher, L. M. (2009). Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins avb6 or avb8. Proc Natl Acad Sci U S A 106, 20464-20469.
4. Chou, S. P., Tsai, C. H., Li, L. Y., Liu, M. Y. & Chen, J. Y. (2004). Characterization of monoclonal antibody to the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2. Hybrid Hybridomics 23, 29-37.
5. Danve, C., Decaussin, G., Busson, P. & Ooka, T. (2001). Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain. Virology 288, 223-235.
6. Fukayama, M., Chong, J. M. & Kaizaki, Y. (1998). Epstein-Barr virus and gastric carcinoma. Gastric Cancer 1, 104-114.
7. Gargouri, B., Van Pelt, J., El Feki, A. F., Attia, H. & Lassoued, S. (2009). Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines. Mol Cell Biochem 324, 55-63.
8. Hammerschmidt, W. & Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
9. Iwasaki, Y., Chong, J. M., Hayashi, Y., Ikeno, R., Arai, K., Kitamura, M., Koike, M., Hirai, K. & Fukayama, M. (1998). Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72, 8321-8326.
10. Kim, N., Chae, H. S., Oh, S. T., Kang, J. H., Park, C. H., Park, W. S., Takada, K., Lee, J. M., Lee, W. K. & Lee, S. K. (2007). Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81, 1033-1036.
11. Kim, N., Song, Y. J. & Lee, S. K. (2011). The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med 43, 401-410.
12. Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menézes, J., Nilsson, K. & Sundstrom, C. (1974). Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A 71, 3283-3286.
13. Middeldorp, J. M., Brink, A. A., van den Brule, A. J. & Meijer, C. J. (2003). Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45, 1-36.
14. Miller, G. & Lipman, M. (1973). Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70, 190-194.
15. Miller, G., Enders, J. F., Lisco, H. & Kohn, H. I. (1969). Establishment of lines from normal human blood leukocytes by co-cultivation with a leukocyte line derived from a leukemic child. Proc Soc Exp Biol Med 132, 247-252.
16. Nemerow, G. R., Mold, C., Schwend, V. K., Tollefson, V. & Cooper, N. R. (1987). Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61, 1416-1420.
17. Oh, S. T., Seo, J. S., Moon, U. Y., Kang, K. H., Shin, D. J., Yoon, S. K., Kim, W. H., Park, J. G. & Lee, S. K. (2004). A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320, 330-336.
18. Park, J. G., Yang, H. K., Kim, W. H., Chung, J. K., Kang, M. S., Lee, J. H., Oh, J. H., Park, H. S., Yeo, K. S. & other authors (1997). Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70, 443-449.
19. Raab-Traub, N. & Flynn, K. (1986). The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47, 883-889.
20. Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A. & Kieff, E. (1990). Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64, 4084-4092.
21. Satoh, T., Fukuda, M. & Sairenji, T. (2002). Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines. Virus Genes 25, 15-21.
22. Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B. & Delecluse, H. J. (2006). Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103,7065-7070.
23. Shimizu, N., Yoshiyama, H. & Takada, K. (1996). Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70, 7260-7263.
24. Sugiura, M., Imai, S., Tokunaga, M., Koizumi, S., Uchizawa, M., Okamoto, K. & Osato, T. (1996). Transcriptional analysis of Epstein Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74, 625-631.
25. Tajima, M., Komuro, M. & Okinaga, K. (1998). Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J Cancer Res 89, 262-268.
26. Takada, K. (2000). Epstein-Barr virus and gastric carcinoma. Mol Pathol 53, 255-261.
27. Takasaka, N., Tajima, M., Okinaga, K., Satoh, Y., Hoshikawa, Y., Katsumoto, T., Kurata, T. & Sairenji, T. (1998). Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Virology 247, 152-159.
28. Teramoto, N., Maeda, A., Kobayashi, K., Hayashi, K., Oka, T., Takahashi, K., Takada, K., Klein, G. & Akagi, T. (2000). Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity. Lab Invest 80, 303-312.
29. Yoshiyama, H., Shimizu, N. & Takada, K. (1995). Persistent Epstein Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J 14, 3706-3711.
30. Yoshiyama, H., Imai, S., Shimizu, N. & Takada, K. (1997). Epstein Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71, 5688-5691.
31. Young, L. S. & Rickinson, A. B. (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768.